Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events

NCT02103101 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulants
Thromboembolism
Hemorrhage

Interventions

OTHER: Measurement of Plasma Concentrations of NOACs
GENETIC: Identification of ABCB1 polymorphisms coding for P-gp

Sponsor

Centre Hospitalier Universitaire de Besancon

Collaborators

[object Object]